Hangzhou Fanttest Biotech Co., Ltd., a leading biotechnology company based in Hangzhou, China, is excited to announce its participation at the upcoming Medlab Middle East exhibition in Dubai on 5-8 February 2024. The company will be exhibiting at Booth No. Z2.C10 and warmly welcomes industry professionals from around the world to visit and explore its latest innovations.
Medlab Middle East is a leading exhibition for medical laboratory technology in the Middle East, providing a platform for industry leaders to showcase their latest products and technologies. Since its establishment in 1998, Medlab Middle East has grown to become a must-attend event for healthcare professionals from the region and beyond.
During the exhibition, Hangzhou Fanttest will highlight its latest products, including the Single and Multi-Drug Rapid Test (Saliva) and the COVID-19+Influenza A&B Antigen Test Kit，Human Papilloma Virus (HPV) Antigen Rapid Test and so on. These innovative products are designed to provide fast, accurate, and easy-to-use solutions The company aims to demonstrate how its technologies can improve patient diagnosis and drive medical research forward in the Middle East and beyond.
"We are delighted to have the opportunity to showcase our products at Medlab Middle East 2024," said a spokesperson for Hangzhou Fanttest. "This exhibition provides us with a prime opportunity to connect with key decision-makers in the healthcare industry and demonstrate the value of our offerings."
Visitors to the Hangzhou Fanttest booth will have the opportunity to learn more about the company's innovative products and services, as well as discuss potential collaborations and business opportunities.
Hanzghou Fanttest is looking forward to your arrival.